ONCY

#3427
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.04
1.04
Rango anual
0.33
1.51
Cambio diario
+10.64%
Variación mensual
+14.29%
Variación en los últimos 6 meses
+4.00%
Cambio anual
+173.68%
Cierres anteriores
0.9 4
Open
1.0 4
Mínimo
1.0 4
High
1.0 4
Volumen
30
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 124.13 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.91
Relación precio/flujo de caja
-169.59

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Noticias